Area Sanitaria Da Coruna E Cee

At Area Sanitaria Da Coruna E Cee, research in immune system diseases focuses on systemic lupus erythematosus, with studies aimed at improving disease control and evaluating the safety and effectiveness of new treatment options.

• Testing a new therapy to better reduce lupus disease activity and improve patient outcomes
• Assessing safety and tolerability while exploring whether treatment can provide stronger symptom control

This work reflects the site’s interest in advancing care for complex autoimmune conditions through more effective and better-tolerated treatment strategies.

Clinical trials in cardiovascular diseases and nutritional and metabolic diseases at this hospital are centered on hypercholesterolemia, severe hypertriglyceridemia, and the primary prevention of atherosclerotic cardiovascular disease, with a clear goal of lowering long-term heart risk.

• Evaluating new approaches to reduce harmful cholesterol and triglyceride levels
• Studying whether treatment can help prevent major cardiovascular events in people at high risk

The research also includes efforts to confirm safety and treatment effectiveness in people who need stronger lipid management.

Oncology studies at Area Sanitaria Da Coruna E Cee are focused on non-small cell lung cancer, including cases with EGFR mutations and EGFR exon 20 insertion mutations, with trials designed to test new treatment combinations and improve outcomes after earlier therapies stop working.

• Testing whether new therapy combinations can extend survival and delay disease progression
• Exploring treatment options for patients whose cancer has progressed after prior targeted therapy

These studies aim to expand options for people with advanced lung cancer and support more effective personalized cancer care.

In nutritional and metabolic diseases, the site is also involved in research on type 2 diabetes mellitus, including studies that look at patient-centered ways to run clinical trials and improve participation in everyday care settings.

• Assessing whether more flexible trial models can improve recruitment, retention, and participant satisfaction
• Supporting better understanding of how new care approaches affect safety, adherence, and data quality

This line of research helps shape more accessible studies for people managing chronic metabolic disease while keeping trial participation practical and patient-friendly.